Table 1.
Epilepsy onset | Epilepsy stage | Raw reads > 500 | Normalised reads > 500 |
p-value < 0.05 FC > 1.4 reads > 500 |
p-value < 0.01 FC > 1.4 reads > 500 |
||||
---|---|---|---|---|---|---|---|---|---|
DESeq2 | limma | DESeq2 | limma | DESeq2 | limma | DESeq2 | limma | ||
Adulthood | Acute | 334 | 348 | 313 | 335 | 36 | 40 | 29 | 40 |
Latent | 370 | 380 | 359 | 371 | 42 | 36 | 37 | 36 | |
Chronic | 394 | 400 | 380 | 385 | 38 | 30 | 21 | 30 | |
Infancy | Acute | 331 | 339 | 324 | 311 | 27 | 25 | 21 | 25 |
Latent | 365 | 380 | 368 | 378 | 3 | 3 | 1 | 3 | |
Chronic | 407 | 419 | 376 | 395 | 12 | 15 | 4 | 15 |
Descriptive results of two workflows of massive parallel sequencing data processing: DESeq2 and limma. The table contains count of miRNAs reaching threshold of 500 reads (both raw and normalised) in each statistical analysis. Counts of miRNAs with fold-change over 1.4, p-value below 0.05 or 0.01 and number of normalised reads above 500 are displayed for each stage of epileptogenesis in both age groups respectively.